Blockchain Registration Transaction Record

Quantum BioPharma Hires IR Agency to Boost Investor Outreach

Quantum BioPharma (NASDAQ: QNTM) enters investor relations agreement with Stocks.news via IR Agency LLC for US$250K. Focus on Lucid-MS for MS and UNBUZZD royalty stream. Boost visibility for neurodegenerative therapies.

This news matters because it signals Quantum BioPharma's proactive strategy to enhance its market visibility and attract investor attention as it advances promising therapies for multiple sclerosis and alcohol misuse. The investor relations agreement with Stocks.news could lead to increased awareness among potential investors, potentially impacting the company's stock liquidity and valuation. For patients and the medical community, greater visibility may accelerate the development and eventual availability of treatments like Lucid-MS, which targets the root cause of MS by preventing and reversing myelin degradation. The royalty stream from UNBUZZD also provides a potential revenue source, strengthening Quantum's financial position to fund further research.